IL144797A0 - A system for cell-based screening - Google Patents
A system for cell-based screeningInfo
- Publication number
- IL144797A0 IL144797A0 IL14479700A IL14479700A IL144797A0 IL 144797 A0 IL144797 A0 IL 144797A0 IL 14479700 A IL14479700 A IL 14479700A IL 14479700 A IL14479700 A IL 14479700A IL 144797 A0 IL144797 A0 IL 144797A0
- Authority
- IL
- Israel
- Prior art keywords
- cells
- cell
- based screening
- kits
- screens
- Prior art date
Links
- 238000012216 screening Methods 0.000 title abstract 2
- 230000008827 biological function Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
- G01N33/5079—Mitochondria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12215299P | 1999-02-26 | 1999-02-26 | |
US12339999P | 1999-03-08 | 1999-03-08 | |
US09/352,171 US6759206B1 (en) | 1997-02-27 | 1999-07-12 | System for cell-based screening |
PCT/US2000/004794 WO2000050872A2 (en) | 1999-02-26 | 2000-02-25 | A system for cell-based screening |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144797A0 true IL144797A0 (en) | 2002-06-30 |
Family
ID=27382740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14479700A IL144797A0 (en) | 1999-02-26 | 2000-02-25 | A system for cell-based screening |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1155304B1 (de) |
JP (1) | JP3576491B2 (de) |
AT (1) | ATE239907T1 (de) |
AU (1) | AU3605600A (de) |
CA (1) | CA2362117C (de) |
DE (1) | DE60002562T2 (de) |
IL (1) | IL144797A0 (de) |
WO (1) | WO2000050872A2 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989835A (en) | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
US7853411B2 (en) | 1997-02-27 | 2010-12-14 | Cellomics, Inc. | System for cell-based screening |
US6759206B1 (en) | 1997-02-27 | 2004-07-06 | Cellomics, Inc. | System for cell-based screening |
US7160687B1 (en) | 1997-05-29 | 2007-01-09 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
US7236888B2 (en) | 1998-03-06 | 2007-06-26 | The Regents Of The University Of California | Method to measure the activation state of signaling pathways in cells |
US7151847B2 (en) | 2001-02-20 | 2006-12-19 | Cytokinetics, Inc. | Image analysis of the golgi complex |
US6651008B1 (en) | 1999-05-14 | 2003-11-18 | Cytokinetics, Inc. | Database system including computer code for predictive cellular bioinformatics |
WO2000070528A2 (en) * | 1999-05-14 | 2000-11-23 | Cytokinetics, Inc. | Method and apparatus for predictive cellular bioinformatics |
US6743576B1 (en) | 1999-05-14 | 2004-06-01 | Cytokinetics, Inc. | Database system for predictive cellular bioinformatics |
WO2000079241A2 (en) * | 1999-06-21 | 2000-12-28 | Cellomics, Inc. | A system for cell-based screening |
WO2001007889A2 (en) * | 1999-07-27 | 2001-02-01 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
WO2001011341A2 (en) * | 1999-08-05 | 2001-02-15 | Cellomics, Inc. | A system for cell-based screening |
US6986993B1 (en) | 1999-08-05 | 2006-01-17 | Cellomics, Inc. | System for cell-based screening |
AU1656401A (en) * | 1999-11-09 | 2001-06-06 | Cellomics, Inc. | A system for cell-based screening |
US6614452B1 (en) | 1999-11-15 | 2003-09-02 | Xenogen Corporation | Graphical user interface for in-vivo imaging |
US7581191B2 (en) | 1999-11-15 | 2009-08-25 | Xenogen Corporation | Graphical user interface for 3-D in-vivo imaging |
AU2073801A (en) | 1999-12-09 | 2001-06-18 | Cellomics, Inc. | A system for cell-based screening |
US7410769B2 (en) | 2000-02-11 | 2008-08-12 | Cellomics Inc. | Peptide biosensors for anthrax protease |
US6775567B2 (en) | 2000-02-25 | 2004-08-10 | Xenogen Corporation | Imaging apparatus |
US20030096315A1 (en) | 2000-05-03 | 2003-05-22 | Sanders Mitchell C. | Device for detecting bacterial contamination and method of use |
EP1356081B1 (de) * | 2000-05-03 | 2006-08-23 | Expressive Constructs, Inc. | Verfahren zum nachweis von listeria monocytogenes |
AU2002230415A1 (en) | 2000-11-17 | 2002-05-27 | Universal Imaging Corporation | Rapidly changing dichroic beamsplitter |
DE60117180T2 (de) * | 2000-11-22 | 2006-08-10 | The Regents Of The University Of California, Oakland | Verfahren zur messung des aktivierungszustands von signalwegen in zellen |
US7218764B2 (en) | 2000-12-04 | 2007-05-15 | Cytokinetics, Inc. | Ploidy classification method |
US7016787B2 (en) | 2001-02-20 | 2006-03-21 | Cytokinetics, Inc. | Characterizing biological stimuli by response curves |
GB2389692B (en) | 2001-02-20 | 2005-06-29 | Cytokinetics Inc | Method and apparatus for automated cellular bioinformatics |
US6956961B2 (en) | 2001-02-20 | 2005-10-18 | Cytokinetics, Inc. | Extracting shape information contained in cell images |
WO2002073200A1 (en) | 2001-03-12 | 2002-09-19 | Cellomics, Inc. | Methods to increase the capacity of high content cell-based screening assays |
WO2002077903A2 (en) | 2001-03-26 | 2002-10-03 | Cellomics, Inc. | Methods for determining the organization of a cellular component of interest |
EP1383911A4 (de) * | 2001-04-02 | 2004-12-15 | Cytoprint Inc | Verfahren und vorrichtungen zur entdeckung, identifizierung und zum vergleich biologischer aktivitätsmechanismen |
EP1576181B1 (de) | 2002-01-31 | 2013-08-14 | Systagenix Wound Management IP Co. BV. | Verfahren zum nachweis pathogenenbakterien in wunden |
US7474399B2 (en) | 2002-02-22 | 2009-01-06 | Xenogen Corporation | Dual illumination system for an imaging apparatus and method |
US7474398B2 (en) | 2002-02-22 | 2009-01-06 | Xenogen Corporation | Illumination system for an imaging apparatus with low profile output device |
US6922246B2 (en) | 2002-02-22 | 2005-07-26 | Xenogen Corporation | Bottom fluorescence illumination assembly for an imaging apparatus |
US20060199220A1 (en) * | 2002-09-16 | 2006-09-07 | Blackburn Jonathan M | Protein arrays and uses thereof |
EP1646926A2 (de) | 2003-07-18 | 2006-04-19 | Cytokinetics, Inc. | Charakterisierung biologischer stimuli durch ansprechkurven |
US7235353B2 (en) | 2003-07-18 | 2007-06-26 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
US20050014217A1 (en) | 2003-07-18 | 2005-01-20 | Cytokinetics, Inc. | Predicting hepatotoxicity using cell based assays |
CA2557612C (en) | 2003-11-03 | 2014-06-17 | Ethicon, Inc. | Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria |
US7323318B2 (en) | 2004-07-15 | 2008-01-29 | Cytokinetics, Inc. | Assay for distinguishing live and dead cells |
CN101151378B (zh) * | 2005-03-30 | 2013-04-03 | 奥林巴斯株式会社 | 规定部位发光量测定方法、规定部位发光量测定装置、表达量测定方法及测定装置 |
JP2007049943A (ja) * | 2005-08-18 | 2007-03-01 | Kyoto Univ | 細胞内カルシウムイオン指示機能を有するポリペプチド |
US8114615B2 (en) | 2006-05-17 | 2012-02-14 | Cernostics, Inc. | Method for automated tissue analysis |
JP5058962B2 (ja) * | 2008-12-22 | 2012-10-24 | オリンパス株式会社 | 細胞画像解析装置、細胞画像解析方法、及びプログラム |
CA2816014A1 (en) | 2010-11-03 | 2012-05-10 | Reametrix Inc. | Method and device for fluorescent measurement of samples |
EP2663337A4 (de) | 2011-01-10 | 2014-06-11 | Harvard College | Verfahren zur abgabe von mitteln in zellen mittels bakterieller toxine |
AU2012229102B2 (en) | 2011-03-17 | 2016-02-04 | Cernostics, Inc. | Systems and compositions for diagnosing Barrett's esophagus and methods of using the same |
EP2817341A4 (de) | 2012-02-23 | 2015-12-02 | Harvard College | Mikrobieller modifizierter toxinrezeptor zur abgabe von mitteln in zellen |
CN104662425B (zh) | 2012-05-02 | 2017-10-10 | 查尔斯河实验室公司 | 活性染色方法 |
WO2013166338A2 (en) | 2012-05-02 | 2013-11-07 | Charles River Laboratories, Inc. | Cell capture system and use thereof |
EP2780707B1 (de) | 2012-05-02 | 2016-02-24 | Charles River Laboratories, Inc. | Nachweisverfahren für lebenfähige zellen in einer zellprobe |
JP5639670B2 (ja) | 2013-02-01 | 2014-12-10 | 浜松ホトニクス株式会社 | 画像取得装置及び撮像装置 |
KR102353589B1 (ko) * | 2014-03-17 | 2022-01-19 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 핵 인자-κB 전위에 근거하여 화합물의 독성을 예측하는 방법 |
ES2739525T3 (es) | 2014-07-23 | 2020-01-31 | Inst Nat Sante Rech Med | Métodos para detectar interacciones en células eucariotas usando estructuras y dinámica de microtúbulos |
CN104483103B (zh) * | 2014-12-22 | 2017-01-04 | 北京市产品质量监督检验院 | 显示屏分辨率的测试方法 |
JP6684643B2 (ja) * | 2016-04-28 | 2020-04-22 | 富士フイルム株式会社 | 生体試料評価システムおよび生体試料評価方法並びに生体試料評価制御プログラム |
CN107290338A (zh) * | 2017-06-19 | 2017-10-24 | 亿信标准认证集团四川有限公司 | 采用图像识别系统的试纸型甲醛检测系统 |
CN108031658A (zh) * | 2017-12-01 | 2018-05-15 | 泰州海天电子科技股份有限公司 | 一种三极管测试编带后印记不良检测方法 |
CN109406769A (zh) * | 2018-09-28 | 2019-03-01 | 李军 | Akr在min6细胞中胰岛素分泌机制研究的应用 |
JP2022511317A (ja) * | 2018-10-15 | 2022-01-31 | マックスプランク-ゲセルシャフト・ツール・フェーデルング・デル・ヴィッセンシャフテン・エー・ファウ | 疾患の治療のための化合物およびこれをスクリーニングする方法 |
US20220206280A1 (en) * | 2020-12-31 | 2022-06-30 | Q-State Biosciences, Inc. | Microscope with spatial imaging and beam homogenizer |
WO2023278672A1 (en) * | 2021-06-30 | 2023-01-05 | Q-State Biosciences, Inc. | Multiplex optical stimulus and readout |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399296B1 (en) * | 1994-07-20 | 2002-06-04 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
ATE268008T1 (de) * | 1997-02-27 | 2004-06-15 | Cellomics Inc | Ein system zur zellbasierten reihenuntersuchung |
DE69804446T3 (de) * | 1997-04-07 | 2006-08-24 | Bioimage A/S | Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen |
-
2000
- 2000-02-25 AU AU36056/00A patent/AU3605600A/en not_active Abandoned
- 2000-02-25 JP JP2000601420A patent/JP3576491B2/ja not_active Expired - Lifetime
- 2000-02-25 AT AT00914701T patent/ATE239907T1/de not_active IP Right Cessation
- 2000-02-25 IL IL14479700A patent/IL144797A0/xx unknown
- 2000-02-25 DE DE60002562T patent/DE60002562T2/de not_active Expired - Lifetime
- 2000-02-25 EP EP00914701A patent/EP1155304B1/de not_active Expired - Lifetime
- 2000-02-25 WO PCT/US2000/004794 patent/WO2000050872A2/en active IP Right Grant
- 2000-02-25 CA CA002362117A patent/CA2362117C/en not_active Expired - Lifetime
- 2000-02-25 EP EP03004224A patent/EP1314980B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60002562T2 (de) | 2004-04-15 |
ATE239907T1 (de) | 2003-05-15 |
EP1155304A2 (de) | 2001-11-21 |
EP1155304B1 (de) | 2003-05-07 |
CA2362117A1 (en) | 2000-08-31 |
WO2000050872A2 (en) | 2000-08-31 |
JP3576491B2 (ja) | 2004-10-13 |
EP1314980A3 (de) | 2004-03-24 |
AU3605600A (en) | 2000-09-14 |
DE60002562D1 (de) | 2003-06-12 |
CA2362117C (en) | 2004-11-30 |
EP1314980B1 (de) | 2009-12-09 |
EP1314980A2 (de) | 2003-05-28 |
WO2000050872A3 (en) | 2001-03-08 |
JP2003526772A (ja) | 2003-09-09 |
WO2000050872A9 (en) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144797A0 (en) | A system for cell-based screening | |
IL142636A0 (en) | A system for cell-based screening | |
IL147793A0 (en) | Optical system analysis of cells | |
WO2001011341A3 (en) | A system for cell-based screening | |
WO2000017643A8 (en) | A system for cell-based screening | |
DK0983498T3 (da) | System for cellebaseret screening | |
DE69835537D1 (de) | Screeningsystem mit hohem durchfluss unter verwendung planarer festphasen | |
HK1090422A1 (en) | A system for determining the electrical potential across a membrane | |
WO2002035260A3 (en) | Light detection device | |
AU6834700A (en) | Device and method for determining multiple analytes | |
GB2391065A (en) | Classifying cells based on information contained in cell images | |
WO2001042786A3 (en) | System for cell based screening : cell spreading | |
WO2000058715A3 (en) | Assay system | |
DE59814441D1 (de) | Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren | |
WO2000070342A3 (en) | Optical system analysis of cells | |
EP1439384A3 (de) | System für Screening biologischer Zellen | |
CA2410688A1 (en) | A system for cell-based screening | |
ATE441099T1 (de) | Zytologisches abbildungssystem und verfahren | |
MX9709597A (es) | DTECCIaN DE POTENCIALES DE TRANSMEMBRANA MEDIANTE MÉTODOS aPTICOS. |